Home 2018
Yearly Archives: 2018
FDA Approves Drugs for Treatment of Two Rare Blood Diseases
Elzonris approved to treat BPDCN; Ultomiris approved for paroxysmal nocturnal hemoglobinuria
HPV Ups Cervical Cancer Risk, Even With No Cellular Signs
HPV-16/18 confers strong future risk, particularly in women younger than 30 years
EMS Treatment for Possible Heart Attack Varies by Sex
Women less likely to receive aspirin, resuscitation, ambulance transport with lights and siren
Vit C for Pregnant Smokers May Improve Newborn Lung Function
Newborn lung function improved as measured by forced expiratory flow at three months of age
Costs, Expected Weight Loss Impact Bariatric Surgery Choice
Complications, recovery time, other risks less influential in decision making
FDA: Fluoroquinolones Tied to Heart Vessel Ruptures, Tears
Patients at risk include those with hypertension or certain genetic disorders and the elderly
FDA: Teething Jewelry Linked to at Least One Infant Death
Threats from these products include choking, strangulation, injury to the mouth, infection
FDA Warns Companies on Unsafe, Unapproved Stem Cell Treatments
Patients contracting deadly infections at clinics offering the unapproved treatments
FDA Announces Safety Monitoring Measures for the Essure Device
Measures include having women in the postmarket surveillance study followed for five years, not three
Incorrect Prescribing Alerts Common for Psychotropic Meds
One-third with electronic Rx system that provides alerts believe system provides incorrect warnings
